comparemela.com

/PRNewswire/ -- KAHR, a clinical-stage biotech company developing DSP107, a novel, bi-specific CD47x4-1BB targeting immunotherapy that activates innate and...

Related Keywords

Chicago ,Illinois ,United States ,Modiin ,Israel General ,Israel ,American ,Tsipi Haitovsky ,Yaron Pereg ,American Society Of Clinical Oncology ,American Society ,Clinical Oncology ,Chief Executive Officer ,Developmental Therapeutics ,Kahr Medical ,

© 2025 Vimarsana

comparemela.com © 2020. All Rights Reserved.